€14.05
0.50% yesterday
Xetra, Nov 22, 05:35 pm CET
ISIN
DE000A288904
Symbol
COP
Index

CompuGroup Medical Stock price

€14.05
+0.48 3.54% 1M
-14.49 50.77% 6M
-23.85 62.93% YTD
-22.95 62.03% 1Y
-58.90 80.74% 3Y
-45.95 76.58% 5Y
-5.20 27.01% 10Y
Xetra, Closing price Fri, Nov 22 2024
-0.07 0.50%
ISIN
DE000A288904
Symbol
COP
Index
Sector

Key metrics

Market capitalization €726.87m
Enterprise Value €1.50b
P/E (TTM) P/E ratio 28.90
EV/FCF (TTM) EV/FCF 12.22
EV/Sales (TTM) EV/Sales 1.31
P/S ratio (TTM) P/S ratio 0.63
P/B ratio (TTM) P/B ratio 1.15
Dividend yield 7.12%
Last dividend (FY23) €1.00
Revenue growth (TTM) Revenue growth -4.65%
Revenue (TTM) Revenue €1.15b
EBIT (operating result TTM) EBIT €120.14m
Free Cash Flow (TTM) Free Cash Flow €123.09m
Cash position €74.97m
EPS (TTM) EPS €0.49
P/E forward 13.69
P/S forward 0.63
EV/Sales forward 1.30
Show more

Is CompuGroup Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

CompuGroup Medical Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a CompuGroup Medical forecast:

5x Buy
56%
4x Hold
44%

Analyst Opinions

9 Analysts have issued a CompuGroup Medical forecast:

Buy
56%
Hold
44%

Financial data from CompuGroup Medical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,152 1,152
5% 5%
100%
- Direct Costs 891 891
3% 3%
77%
262 262
24% 24%
23%
- Selling and Administrative Expenses 23 23
68% 68%
2%
- Research and Development Expense - -
-
-
239 239
12% 12%
21%
- Depreciation and Amortization 119 119
8% 8%
10%
EBIT (Operating Income) EBIT 120 120
26% 26%
10%
Net Profit 25 25
67% 67%
2%

In millions EUR.

Don't miss a Thing! We will send you all news about CompuGroup Medical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CompuGroup Medical Stock News

EQS
16 days ago
Das bereinigte EBITDA ging im selben Zeitraum um 12 Prozent auf 54,9 Mio. Euro (Vj.: 62,2 Mio. Euro) zurück. Die EBITDA-Marge lag bei 19 Prozent (Vj.: 22 Prozent). Dies ist neben dem Umsatzrückgang im Wesentlichen auf Investitionen in innovative Produkte und Lösungen zurückzuführen. Die Aufwendun...
AD HOC NEWS
16 days ago
Die Aktien von Compugroup Medical DE000A288904 haben am Donnerstag von den Quartalszahlen des auf Arztpraxen und Krankenhäuser spezialisierten Softwareanbieters Auftrieb erhalten.
AD HOC NEWS
16 days ago
Die Baader Bank hat die Einstufung für Compugroup DE000A288904 nach Zahlen zum dritten Quartal auf "Buy" mit einem Kursziel von 30 Euro belassen.
More CompuGroup Medical News

Company Profile

CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. Its software products are designed to support all medical and organizational activities in doctor’s office, pharmacies, laboratories and hospitals. The company operates through the following segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Health Connectivity Services (HCS). The AIS segment focuses on practice management software and electronic medical records for office-based physicians, dentists, medical care centers and physician's networks. The PCS segment focuses on integrated clinical, administrative and financial software applications for retail pharmacies. The HIS segment focuses on clinical and administrative solutions for the inpatient sector, where health services are provided over a prolonged period of time through highly specialized, secondary care institutions. The HCS segment on customers within the healthcare sector that are outside the healthcare providers. The company was founded by Frank Gotthardt in 1987 and is headquartered in Koblenz, Germany.

Head office Germany
CEO Daniel Gotthardt
Employees 9,199
Founded 1987
Website www.cgm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today